BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 22425762)

  • 21. A novel liquidchip platform for simultaneous detection of 70 alleles of DNA somatic mutations on EGFR, KRAS, BRAF and PIK3CA from formalin-fixed and paraffin-embedded slides containing tumor tissue.
    Li G; Luo X; He J; Zhu Z; Yu G; Qin H; Zeng T; Liu Z; Wu S; Xu J; Ren-Heidenreich L
    Clin Chem Lab Med; 2011 Feb; 49(2):191-5. PubMed ID: 21118047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of next-generation sequencing and mutation-specific platforms in clinical practice.
    Hinrichs JW; van Blokland WT; Moons MJ; Radersma RD; Radersma-van Loon JH; de Voijs CM; Rappel SB; Koudijs MJ; Besselink NJ; Willems SM; de Weger RA
    Am J Clin Pathol; 2015 Apr; 143(4):573-8. PubMed ID: 25780010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KRAS and BRAF mutation analysis in colorectal adenocarcinoma specimens with a low percentage of tumor cells.
    Lewandowska MA; Jóźwicki W; Żurawski B
    Mol Diagn Ther; 2013 Jun; 17(3):193-203. PubMed ID: 23606169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KRAS mutation detection in Tunisian sporadic coloractal cancer patients with direct sequencing, high resolution melting and denaturating high performance liquid chromatography.
    Karim B; Florence C; Kamel R; Nadia K; Ines O; Raja M; Sarra BJ; Florent S; Amel BA
    Cancer Biomark; 2010-2011; 8(6):331-40. PubMed ID: 22072121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of COBAS 4800 KRAS, TaqMan PCR and high resolution melting PCR assays for the detection of KRAS somatic mutations in formalin-fixed paraffin embedded colorectal carcinomas.
    Harlé A; Busser B; Rouyer M; Harter V; Genin P; Leroux A; Merlin JL
    Virchows Arch; 2013 Mar; 462(3):329-35. PubMed ID: 23400679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing.
    Sakai K; Tsurutani J; Yamanaka T; Yoneshige A; Ito A; Togashi Y; De Velasco MA; Terashima M; Fujita Y; Tomida S; Tamura T; Nakagawa K; Nishio K
    PLoS One; 2015; 10(5):e0121891. PubMed ID: 25954997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quick-multiplex-consensus (QMC)-PCR followed by high-resolution melting: a simple and robust method for mutation detection in formalin-fixed paraffin-embedded tissue.
    Fadhil W; Ibrahem S; Seth R; Ilyas M
    J Clin Pathol; 2010 Feb; 63(2):134-40. PubMed ID: 20154035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-time detection of BRAF V600E mutation from archival hairy cell leukemia FFPE tissue by nanopore sequencing.
    Vacca D; Cancila V; Gulino A; Lo Bosco G; Belmonte B; Di Napoli A; Florena AM; Tripodo C; Arancio W
    Mol Biol Rep; 2018 Feb; 45(1):1-7. PubMed ID: 29238890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiplatform comparison of molecular oncology tests performed on cytology specimens and formalin-fixed, paraffin-embedded tissue.
    Gailey MP; Stence AA; Jensen CS; Ma D
    Cancer Cytopathol; 2015 Jan; 123(1):30-9. PubMed ID: 25186473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Applicability of a System for fully automated nucleic acid extraction from formalin-fixed paraffin-embedded sections for routine KRAS mutation testing.
    Lehmann A; Schewe C; Hennig G; Denkert C; Weichert W; Budczies J; Dietel M
    Diagn Mol Pathol; 2012 Jun; 21(2):114-9. PubMed ID: 22555094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cycleave polymerase chain reaction method is practically applicable for V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)/V-raf murine sarcoma viral oncogene homolog B1 (BRAF) genotyping in colorectal cancer.
    Yokota T; Shibata N; Ura T; Takahari D; Shitara K; Muro K; Yatabe Y
    Transl Res; 2010 Aug; 156(2):98-105. PubMed ID: 20627194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of KRAS codon 12 and 13 mutations by mutant-enriched PCR assay.
    Chang YS; Er TK; Lu HC; Yeh KT; Chang JG
    Clin Chim Acta; 2014 Sep; 436():169-75. PubMed ID: 24863805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.
    Seth R; Crook S; Ibrahem S; Fadhil W; Jackson D; Ilyas M
    Gut; 2009 Sep; 58(9):1234-41. PubMed ID: 19474002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KRAS and BRAF mutation analysis from liquid-based cytology brushings of colorectal carcinoma in comparison with formalin-fixed, paraffin-embedded tissue.
    Spathis A; Georgoulakis J; Foukas P; Kefala M; Leventakos K; Machairas A; Panayiotides I; Karakitsos P
    Anticancer Res; 2010 Jun; 30(6):1969-75. PubMed ID: 20651341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of KRAS mutations in colorectal cancer by high-resolution melting analysis.
    Ma ES; Wong CL; Law FB; Chan WK; Siu D
    J Clin Pathol; 2009 Oct; 62(10):886-91. PubMed ID: 19783717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concordance in KRAS and BRAF mutations in endoscopic biopsy samples and resection specimens of colorectal adenocarcinoma.
    Krol LC; 't Hart NA; Methorst N; Knol AJ; Prinsen C; Boers JE
    Eur J Cancer; 2012 May; 48(7):1108-15. PubMed ID: 22446020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KRAS detection in colonic tumors by DNA extraction from FTA paper: the molecular touch-prep.
    Petras ML; Lefferts JA; Ward BP; Suriawinata AA; Tsongalis GJ
    Diagn Mol Pathol; 2011 Dec; 20(4):189-93. PubMed ID: 22089345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization of routine KRAS mutation PCR-based testing procedure for rational individualized first-line-targeted therapy selection in metastatic colorectal cancer.
    Chretien AS; Harlé A; Meyer-Lefebvre M; Rouyer M; Husson M; Ramacci C; Harter V; Genin P; Leroux A; Merlin JL
    Cancer Med; 2013 Feb; 2(1):11-20. PubMed ID: 24133623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of EGFR and KRAS mutations on trans-thoracic needle aspiration of lung nodules by high resolution melting analysis.
    Fassina A; Gazziero A; Zardo D; Corradin M; Aldighieri E; Rossi GP
    J Clin Pathol; 2009 Dec; 62(12):1096-102. PubMed ID: 19640859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patients.
    Mohamed Suhaimi NA; Foong YM; Lee DY; Phyo WM; Cima I; Lee EX; Goh WL; Lim WY; Chia KS; Kong SL; Gong M; Lim B; Hillmer AM; Koh PK; Ying JY; Tan MH
    Mol Oncol; 2015 Apr; 9(4):850-60. PubMed ID: 25605225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.